Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01869660

Shared Decision Making for Patients With First-admission Schizophrenia

Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial

Sponsor: Yokohama City University

Updated 5 times since 2017 Last updated: Dec 29, 2015 Started: Jun 30, 2013 Primary completion: Apr 30, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Schizophrenia and is currently completed. Yokohama City University leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yokohama City University

Data source: Yokohama City University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Numazu, Japan